-
Mashup Score: 2Flurpiridaz Clinical Trial Results Will be Announced at ASNC2022 - 2 year(s) ago
August 12, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron Emission Tomography (PET) Imaging Assessment of Myocardial Perfusion in Patients Referred for Invasive Angiography Because of Suspected Coronary Artery Disease (CAD)” will be presented for the first time at ASNC’s 27th Annual Scientific Session and Exhibition, which will…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
@DAICeditor @MyASNC Results of “A Phase 3, Open-label, Multicenter Study of #Flurpiridaz Injection for #PET Imaging Assessment of #MyocardialPerfusion in Patients Referred for Invasive #Angiography Because of Suspected #CAD” will be presented at #ASNC22: https://t.co/pZKixcaMht